Antihypercholesterolemic potential of bioactive compounds in Phaseolus vulgaris: A narrative review
DOI: https://doi.org/10.33024/minh.v9i5.1447
Active Compounds Hypercholesterolemia Legumes Phaseolus vulgaris L
Abstract
Background: Hypercholesterolemia is a metabolic disorder characterized by increased cholesterol levels, especially low-density lipoprotein (LDL), in the blood circulation. This condition contributes significantly to the incidence of coronary heart disease and stroke, and is a global public health burden. Standard therapy using lipid-lowering drugs such as statins has been proven effective, but is associated with adverse effects, such as myopathy, hepatotoxicity, and long-term treatment resistance. Therefore, the search for safer and more affordable natural therapeutic alternatives is important. One potential plant that is widely consumed and relatively safe is beans (Phaseolus vulgaris L.).
Purpose: To narratively review scientific evidence related to the hypercholesterolemic activity of bioactive compounds in beans (Phaseolus vulgaris L.) based on in vitro and in vivo research results.
Method: This narrative review involved a literature search conducted in three electronic databases: Google Scholar (n = 58), ScienceDirect (n = 11), and PubMed (n = 2), yielding a total of 71 articles. The search strategy employed Boolean operators using the following keywords: ("beans" AND "Phaseolus vulgaris L." AND "hypercholesterolemia" AND "bioactive compounds" AND "isolation") OR "fractionation". The inclusion criteria comprised original research articles published between 2015 and 2025, with full-text availability. Articles were excluded if they were duplicates, did not present primary research data, or had titles that were not relevant to the predefined search keywords.
Results: Bioactive compounds in Phaseolus vulgaris L. work through multiple mechanisms, including inhibition of cholesterol synthesis, increased excretion, and protection against LDL oxidation. Phaseolus vulgaris demonstrates considerable therapeutic potential as a safe and effective herbal therapy in the management of hypercholesterolemia.
Conclusion: Current preclinical evidence indicates that bioactive compounds in Phaseolus vulgaris may support cholesterol reduction through several complementary mechanisms. However, well-designed human clinical trials are required to confirm their efficacy and safety.
Downloads
References
Alharbi, M. (2016). Characterization of extraction method`s to recover phenolic-rich extracts from black beans (Phaseolus vulgaris) that Inhibit alpha-amylase and alpha-glucosidase using response surface approaches. (Thesis, University of Nebraska)
Almuaigel, M. F., Seif, M. A., Albuali, H. W., Alharbi, O., & Alhawash, A. (2017). Hypoglycemic and hypolipidemic effects of aqueous extract of Phaseolus vulgaris pods in streptozotocin-diabetic rats. Biomedicine & Pharmacotherapy, 94, 742-746.
Angeles, J. G. C., Villanueva, J. C., Uy, L. Y. C., Mercado, S. M. Q., Tsuchiya, M. C. L., Lado, J. P., & Torio, M. A. O. (2021). Legumes as functional food for cardiovascular disease. Applied Sciences, 11(12), 5475.
Ashraf, J., Liu, L., Awais, M., Xiao, T., Wang, L., Zhou, X., & Zhou, S. (2020). Effect of thermosonication pre-treatment on mung bean (Vigna radiata) and white kidney bean (Phaseolus vulgaris) proteins: Enzymatic hydrolysis, cholesterol lowering activity and structural characterization. Ultrasonics Sonochemistry, 66, 105121.
Bhide, Y. S., Nehete, J. Y., & Bhambar, R. S. (2022). Botanical, chemical and pharmacological review of Phaseolus vulgaris L. (common bean): An ayurvedic medicinal plant. International Journal of Health Sciences, 6(S5), 11527-11543.
Bladé, C., Baselga‐Escudero, L., Salvadó, M. J., & Arola‐Arnal, A. (2013). miRNAs, polyphenols, and chronic disease. Molecular nutrition & food research, 57(1), 58-70.
Bolayo, Y., & Torio, M. A. (2024). Anti-hypertensive and anti-hypercholesterolemic effects of protein hydrolysates from (Phaseolus vulgaris) L. in functional beverage. Jurnal Gizi dan Pangan, 19(2), 107-116.
Caponio, G. R., Wang, D. Q. H., Di Ciaula, A., De Angelis, M., & Portincasa, P. (2020). Regulation of cholesterol metabolism by bioactive components of soy proteins: Novel translational evidence. International Journal of Molecular Sciences, 22(1), 227.
Chávez-Santoscoy, R. A., Gutierrez-Uribe, J. A., Granados, O., Torre-Villalvazo, I., Serna-Saldivar, S. O., Torres, N., & Tovar, A. R. (2015). Flavonoids and saponins extracted from black bean (Phaseolus vulgaris L.) seed coats modulate lipid metabolism and biliary cholesterol secretion in C57BL/6 mice. British journal of nutrition, 112(6), 886-899.
Diniatik, D., Lestari, D. I., & Galistiani, G. F. (2021). Studi etnofarmakologi tumbuhan sebagai obat tradisional untuk pencegahan penyakit hiperlipidemia di Kecamatan Dayeuhluhur Kabupaten Cilacap. Jurnal Ilmiah Teknosains. 7(2),
Dominguez-Uscanga, A., Loarca-Piña, G., & de Mejia, E. G. (2017). Baked corn (Zea mays L.) and bean (Phaseolus vulgaris L.) snack consumption lowered serum lipids and differentiated liver gene expression in C57BL/6 mice fed a high-fat diet by inhibiting PPARγ and SREBF2. The Journal of Nutritional Biochemistry, 50, 1-15.
Gabriele, M., Pucci, L., La Marca, M., Lucchesi, D., Della Croce, C. M., Longo, V., & Lubrano, V. (2016). A fermented bean flour extract downregulates LOX-1, CHOP and ICAM-1 in HMEC-1 stimulated by ox-LDL. Cellular & Molecular Biology Letters, 21(1), 1-10.
García-Cordero, J. M., Martínez-Palma, N. Y., Madrigal-Bujaidar, E., Jiménez-Martínez, C., Madrigal-Santillán, E., Morales-González, J. A., & Álvarez-González, I. (2021). Phaseolin, a protein from the seed of Phaseolus vulgaris, has antioxidant, antigenotoxic, and chemopreventive properties. Nutrients, 13(6), 1750.
Kuasnei, M., Leonarski, E., Dartora, M., Bredun, M. A., Burin, V. M., Cesca, K., & Zielinski, A. A. F. (2025). In vitro antioxidant, antiglycemic, and antitumor potential of anthocyanin-rich extracts from black bean hulls obtained by pressurized liquid extraction. ACS Food Science & Technology, 5(2), 670-677.
Nyau, V. (2014). Nutraceutical perspectives and utilization of common beans (Phaseolus vulgaris L.): A review. African Journal of Food, Agriculture, Nutrition and Development, 14(7), 9483-9496.
Ramírez-Jiménez, A. K., Reynoso-Camacho, R., Tejero, M. E., León-Galván, F., & Loarca-Pina, G. (2015). Potential role of bioactive compounds of Phaseolus vulgaris L. on lipid-lowering mechanisms. Food Research International, 76, 92-104.
Sevilla, M. T., López, Z., & Knauth, P. (2020). Common beans (Phaseolus vulgaris L.) and their relationship with chronic diseases of metabolic origin. Medicinal Plants For, 51.
Sulastri, L., Syafalia, P., & Isa, A. F. (2020). Pengaruh fraksinasi buncis (Phaseolus vulgaris L.) terhadap penurunan kadar kolesterol tikus putih (Rattus norvegicus L.) yang hiperkolesterolemia. Jurnal Farmamedika, 5(1), 14-20.
Thompson, H. J., McGinley, J. N., Neil, E. S., & Brick, M. A. (2017). Beneficial effects of common bean on adiposity and lipid metabolism. Nutrients, 9(9), 998.
Verbeek, R., Hoogeveen, R. M., Langsted, A., Stiekema, L. C., Verweij, S. L., Hovingh, G. K., & Stroes, E. S. (2018). Cardiovascular disease risk associated with elevated lipoprotein (a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting. European heart journal, 39(27), 2589-2596.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Diniatik
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
